Firazyr

Firazyr Warnings and Precautions

• Laryngeal attacks: Patients experiencing a laryngeal (throat) HAE attack should seek immediate medical attention in an appropriate healthcare setting, in addition to using Firazyr.
• Injection site reactions: Common and can include pain, swelling, redness, and itching at the injection site.
• Product inspection: The solution should be clear and colorless — do not use if particulates or discoloration are present.

How to Access Firazyr in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Firazyr to India?

Firazyr (icatibant) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified allergist or immunologist
• The patient's diagnostic reports confirming hereditary angioedema
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Firazyr available in India?

Firazyr (icatibant injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Firazyr is not commercially marketed in India.

However, patients in India can legally access Firazyr through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Firazyr received US FDA approval in 2011 for acute attacks of hereditary angioedema, ensuring full transparency throughout the process.

Firazyr can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Firazyr

Firazyr is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 2°C to 25°C, not frozen
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital — designed for patients to keep on hand for emergency use

Availability of Firazyr Across Major Cities in India

Named Patient Program supports access to Firazyr for patients with hereditary angioedema across major cities in India, coordinating documentation, sourcing, and delivery with treating specialists.

Mumbai

Patients in Mumbai can access Firazyr through NPP with support from treating allergists and immunologists.

Delhi

In Delhi, NPP coordinates with hospitals and specialty allergy clinics to facilitate timely access to Firazyr.

Bangalore

Bangalore's allergy and immunology centers work with NPP to support patients requiring Firazyr.

Chennai

Patients in Chennai can access Firazyr through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's allergy and immunology centers support diagnosis and access coordination for Firazyr through NPP.

Kolkata

NPP facilitates access to Firazyr for patients in Kolkata under the guidance of treating specialists.

Pune

Patients in Pune can access Firazyr through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Firazyr for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Firazyr through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Firazyr for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Firazyr through NPP with support from treating specialists.

Lucknow

NPP facilitates access to Firazyr for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Firazyr through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Firazyr for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.